Search details
1.
Clinical Translation: Targeting the Estrogen Receptor.
Adv Exp Med Biol
; 1390: 297-309, 2022.
Article
in English
| MEDLINE | ID: mdl-36107326
2.
A multicenter, single-arm, open-label, phase 2 study of apitolisib (GDC-0980) for the treatment of recurrent or persistent endometrial carcinoma (MAGGIE study).
Cancer
; 122(22): 3519-3528, 2016 Nov 15.
Article
in English
| MEDLINE | ID: mdl-27603005
3.
Response and resistance to MEK inhibition in leukaemias initiated by hyperactive Ras.
Nature
; 461(7262): 411-4, 2009 Sep 17.
Article
in English
| MEDLINE | ID: mdl-19727076
4.
Costello and cardio-facio-cutaneous syndromes: Moving toward clinical trials in RASopathies.
Am J Med Genet C Semin Med Genet
; 157C(2): 136-46, 2011 May 15.
Article
in English
| MEDLINE | ID: mdl-21495172
5.
A Collaborative Model for Accelerating the Discovery and Translation of Cancer Therapies.
Cancer Res
; 77(21): 5706-5711, 2017 11 01.
Article
in English
| MEDLINE | ID: mdl-28993414
6.
Phase I Study of GDC-0425, a Checkpoint Kinase 1 Inhibitor, in Combination with Gemcitabine in Patients with Refractory Solid Tumors.
Clin Cancer Res
; 23(10): 2423-2432, 2017 May 15.
Article
in English
| MEDLINE | ID: mdl-27815358
7.
Phase I Study of Apitolisib (GDC-0980), Dual Phosphatidylinositol-3-Kinase and Mammalian Target of Rapamycin Kinase Inhibitor, in Patients with Advanced Solid Tumors.
Clin Cancer Res
; 22(12): 2874-84, 2016 06 15.
Article
in English
| MEDLINE | ID: mdl-26787751
8.
Sustained MEK inhibition abrogates myeloproliferative disease in Nf1 mutant mice.
J Clin Invest
; 123(1): 335-9, 2013 Jan.
Article
in English
| MEDLINE | ID: mdl-23221337
9.
A MEK inhibitor abrogates myeloproliferative disease in Kras mutant mice.
Sci Transl Med
; 3(76): 76ra27, 2011 Mar 30.
Article
in English
| MEDLINE | ID: mdl-21451123
10.
Sustained MEK inhibition abrogates myeloproliferative disease in Nf1 mutant mice.
J Clin Invest
; 126(1): 404, 2016 Jan.
Article
in English
| MEDLINE | ID: mdl-26727232
11.
Beta common receptor inactivation attenuates myeloproliferative disease in Nf1 mutant mice.
Blood
; 109(4): 1687-91, 2007 Feb 15.
Article
in English
| MEDLINE | ID: mdl-17090653
12.
Inherited predispositions and hyperactive Ras in myeloid leukemogenesis.
Pediatr Blood Cancer
; 46(5): 579-85, 2006 May 01.
Article
in English
| MEDLINE | ID: mdl-16261595
13.
Isolation and analysis of candidate myeloid tumor suppressor genes from a commonly deleted segment of 7q22.
Genomics
; 85(5): 600-7, 2005 May.
Article
in English
| MEDLINE | ID: mdl-15820312
14.
Somatic inactivation of Nf1 in hematopoietic cells results in a progressive myeloproliferative disorder.
Blood
; 103(11): 4243-50, 2004 Jun 01.
Article
in English
| MEDLINE | ID: mdl-14982883
Results
1 -
14
de 14
1
Next >
>>